ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
5
views
0
references
Top references
cited by
38
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,367
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.
Author(s):
S Opat
,
S. H. Oh
,
Alex Shortt
Publication date:
2013-01-03
Journal:
The New England journal of medicine
Keywords:
ADAM Proteins
,
immunology
,
Autoantibodies
,
blood
,
B-Lymphocytes
,
drug effects
,
Boronic Acids
,
pharmacology
,
therapeutic use
,
Female
,
Humans
,
Immunosuppressive Agents
,
Middle Aged
,
Plasma Cells
,
Protease Inhibitors
,
Purpura, Thrombotic Thrombocytopenic
,
drug therapy
,
Pyrazines
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free article)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Drug_transporters
Author and article information
Journal
PubMed ID::
23281998
DOI::
10.1056/NEJMc1213206
ScienceOpen disciplines:
Chemistry
Keywords:
ADAM Proteins
,
immunology
,
Autoantibodies
,
blood
,
B-Lymphocytes
,
drug effects
,
Boronic Acids
,
pharmacology
,
therapeutic use
,
Female
,
Humans
,
Immunosuppressive Agents
,
Middle Aged
,
Plasma Cells
,
Protease Inhibitors
,
Purpura, Thrombotic Thrombocytopenic
,
drug therapy
,
Pyrazines
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
ADAM Proteins
,
immunology
,
Autoantibodies
,
blood
,
B-Lymphocytes
,
drug effects
,
Boronic Acids
,
pharmacology
,
therapeutic use
,
Female
,
Humans
,
Immunosuppressive Agents
,
Middle Aged
,
Plasma Cells
,
Protease Inhibitors
,
Purpura, Thrombotic Thrombocytopenic
,
drug therapy
,
Pyrazines
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,367
B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy
Authors:
Paola Giordano
,
Simona Cascioli
,
Giuseppe Lassandro
…
Systemic review: efficacy and safety of rituximab for adults with immune thrombocytopenic purpura
Authors:
D. N. Arnold
,
F Dentali
,
M. R. Crowther
Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura.
Authors:
Ming Hou
,
Xiaojuan Zhu
,
Jing-Ping Zhao
…
See all similar
Cited by
38
Mechanisms of Autoantibody-Induced Pathology
Authors:
Ralf Ludwig
,
Karen Vanhoorelbeke
,
Frank Leypoldt
…
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
Authors:
Senthil Sukumar
,
Bernhard Lämmle
,
Spero R. Cataland
Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.
Authors:
Christopher Patriquin
,
Mari Thomas
,
Tina Dutt
…
See all cited by